Pavel Buzadzhi
Acute Care · Tulsa, OKNPI 1790318426
Payments from drug & device makers
Across 641 payments — averaging $40.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Abiomed$4K
- United Therapeutics Corporation$3K
- Cvrx, Inc.$2K
- Actelion Pharmaceuticals US, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- plus $7K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 94 | $8,258 |
| Abiomed | 29 | $3,961 |
| United Therapeutics Corporation | 62 | $2,538 |
| Cvrx, Inc. | 22 | $2,071 |
| Actelion Pharmaceuticals US, Inc. | 55 | $1,337 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 43 | $1,062 |
| AstraZeneca | 33 | $1,059 |
| Merck | 50 | $1,015 |
| Alnylam Pharmaceuticals Inc. | 22 | $994 |
| Novartis | 63 | $755 |
| Pfizer | 54 | $648 |
| Bayer | 19 | $390 |
| Boehringer Ingelheim | 20 | $336 |
| Lexicon Pharmaceuticals, Inc. | 10 | $276 |
| Novo Nordisk | 9 | $266 |
| E.r. Squibb & Sons, L.L.C. | 15 | $253 |
| Ancora Heart, Inc. | 9 | $144 |
| Johnson & Johnson | 7 | $119 |
| Akcea Therapeutics, Inc. | 1 | $107 |
| Impulse Dynamics (USA) Inc. | 6 | $105 |
| Scpharmaceuticals Inc. | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 2 | $59 |
| Nuwellis, Inc. | 2 | $56 |
| Amgen | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $41 |
| Philips North America LLC | 1 | $32 |
| Edwards Lifesciences | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $19 |
How this compares
$26,109 in reported general payments places this provider in the 95th percentile of 266 acute care providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Tulsa
- Jerrie MoralesTulsa$15K
- Lisa ArmstrongTulsa$14K
- Ganna StarkeyTulsa$14K
- Jasmine ThompsonTulsa$12K
- Christina HulseyTulsa$9K
- Brandon KingTulsa$9K
- Christina OverlyTulsa$8K
- Brian HutchinsonTulsa$7K
- Mallory NealTulsa$7K
- Julie SpearsTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.